Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β)

Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β)

US Patent 7667027 · Granted Feb 23, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stable polymorphic form of 6-fluoro-9-methyl-9H-β-carboline and uses thereof2025
Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione2024
Method for solubilizing poorly water-soluble dietary supplements and pharmaceuti2022
Method for solubilizing poorly water-soluble cosmetic agents2021
Methhod for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-d2021
Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione2021
Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic prog2021
Agents for the treatment of retroviral infectious diseases2020
Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharma2019
Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, phar2015
Method for selective oligonucleotide modification2015
Dosage of oligonucleotides suitable for the treatment of tumors2014